Literature DB >> 11513565

Tumour dormancy: findings and hypotheses from clinical research on breast cancer.

R Demicheli1.   

Abstract

Breast cancer metastatic development is commonly considered as resulting from continuous tumour growth from tumour seeding until clinical recurrence is documented. Continuous growth model inferences, however, fail to explain clinical findings concerning local recurrences, as well as the time-distribution of first treatment failure and mortality for patients undergoing mastectomy. The tumour dormancy hypothesis is considered to provide a more reasonable description of the natural history of breast cancer, while primary tumour removal is believed to be a potential perturbing factor for metastasis development. A new model of the natural history of operable breast cancer, incorporating tumour dormancy and starting signals from surgery for micrometastatic growth is proposed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11513565     DOI: 10.1006/scbi.2001.0385

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  50 in total

Review 1.  T cell memory, anergy and immunotherapy in breast cancer.

Authors:  Volker Schirrmacher; Markus Feuerer; Philipp Beckhove; Thorsten Ahlert; Viktor Umansky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  The ROCO kinase QkgA is necessary for proliferation inhibition by autocrine signals in Dictyostelium discoideum.

Authors:  Jonathan E Phillips; Richard H Gomer
Journal:  Eukaryot Cell       Date:  2010-08-13

3.  Late-occurring liver metastases in colorectal cancer.

Authors:  Francisco Rodríguez-Moranta; Antoni Castells; Rosa Miquel; Virginia Piñol; Joan Maurel; Josep Fuster; Antonio M Lacy; Josep M Piqué
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  A secreted factor represses cell proliferation in Dictyostelium.

Authors:  Debra A Brock; Richard H Gomer
Journal:  Development       Date:  2005-09-21       Impact factor: 6.868

Review 5.  Dormancy of metastatic melanoma.

Authors:  Liliana Ossowski; Julio A Aguirre-Ghiso
Journal:  Pigment Cell Melanoma Res       Date:  2009-10-19       Impact factor: 4.693

6.  Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency.

Authors:  Mika Suzuki; Evangeline Sari Mose; Valerie Montel; David Tarin
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

7.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis.

Authors:  S Ghosh; S Elankumaran; I K Puri
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

8.  Cancer-immune equilibrium: questions unanswered.

Authors:  Alka Bhatia; Yashwant Kumar
Journal:  Cancer Microenviron       Date:  2011-05-24

9.  Time to breast cancer relapse predicted by primary tumour characteristics, not lymph node involvement.

Authors:  Danielle J Fitzpatrick; Christine S Lai; Robert F Parkyn; David Walters; Vladimir Humeniuk; David C A Walsh
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

Review 10.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.